{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:14:49Z","timestamp":1793279689980,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The glyoxalase system, particularly Glyoxalase-I (Glo-I), plays a crucial role in detoxifying aldehyde metabolites into lactic acid. Inhibiting this enzyme causes the buildup of the poisonous aldehyde, leading to programmed cell death. In this study, molecular modelling techniques were employed, including high-throughput virtual screening (HTVS), followed by filtration procedures such as Lipinski\u2019s rule of five and Veber\u2019s rules, and finally CDOCKER docking, to prioritize compounds from the commercial Maybridge database. Sixteen compounds were carefully chosen and purchased from the Maybridge database for further experimental evaluation. The integrated computational and experimental workflow successfully culminated in the identification of a novel, potent Glyoxalase-I (Glo-I) inhibitor. One molecule has been discovered to inhibit Glo-I with an\n                    <jats:bold>IC<\/jats:bold>\n                    <jats:sub>\n                      <jats:bold>50<\/jats:bold>\n                    <\/jats:sub>\n                    <jats:bold>of 11.1 \u00b5M<\/jats:bold>\n                    . An analysis of the molecular dynamics of the active ligand (\n                    <jats:bold>SPB07393SC<\/jats:bold>\n                    ) reveals stable behaviour. Crucially, this molecule incorporates a unique hydroxy triazole moiety, representing the first reported instance of this zinc-coordinating group in a Glo-I inhibitor. This will be utilized for the purpose of developing novel compounds with enhanced activity following appropriate modifications.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-40497-4","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:59:09Z","timestamp":1771516749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Discovery of hydroxytriazole as a potential glyoxalase-I inhibitor utilizing computer-aided drug design techniques"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5723-6247","authenticated-orcid":false,"given":"MohammedBashar","family":"Al-Qazzan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8350-900X","authenticated-orcid":false,"given":"Qosay","family":"Al-Balas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-1792","authenticated-orcid":false,"given":"Belal","family":"Alnajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3842-7419","authenticated-orcid":false,"given":"Mohammed","family":"Al-Akeedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"issue":"1","key":"40497_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-015-0321-5","volume":"14","author":"Z Su","year":"2015","unstructured":"Su, Z., Yang, Z., Xu, Y., Chen, Y. & Yu, Q. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol. Cancer 14 (1), 48. https:\/\/doi.org\/10.1186\/s12943-015-0321-5 (2015).","journal-title":"Mol. Cancer"},{"issue":"1","key":"40497_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J. Clin. 64 (1), 9\u201329. https:\/\/doi.org\/10.3322\/caac.21208 (2014).","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"40497_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0006-291x(69)90445-8","volume":"35","author":"R Vince","year":"1969","unstructured":"Vince, R. & Wadd, W. B. Glyoxalase inhibitors as potential anticancer agents. Biochem. Biophys. Res. Commun. 35 (5), 593\u2013598. https:\/\/doi.org\/10.1016\/0006-291x(69)90445-8 (1969).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"40497_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1021\/jm00283a009","volume":"14","author":"R Vince","year":"1971","unstructured":"Vince, R. & Daluge, S. Glyoxalase inhibitors. A possible approach to anticancer agents. J. Med. Chem. 14 (1), 35\u201337. https:\/\/doi.org\/10.1021\/jm00283a009 (1971).","journal-title":"J. Med. Chem."},{"issue":"10","key":"40497_CR5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1159\/000367800","volume":"37","author":"X Geng","year":"2014","unstructured":"Geng, X., Ma, J., Zhang, F. & Xu, C. Glyoxalase I in tumor cell proliferation and survival and as a potential target for anticancer therapy. Oncol. Res. Treat. 37 (10), 570\u2013574. https:\/\/doi.org\/10.1159\/000367800 (2014).","journal-title":"Oncol. Res. Treat."},{"issue":"2","key":"40497_CR6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0021-9258(18)56017-8","volume":"190","author":"E Racker","year":"1951","unstructured":"Racker, E. The mechanism of action of glyoxalase. J. Biol. Chem. 190 (2), 685\u2013696 (1951).","journal-title":"J. Biol. Chem."},{"key":"40497_CR7","volume-title":"Functions of Glutathione : Biochemical, Physiological, Toxicological, and Clinical Aspects","author":"A Larsson","year":"1983","unstructured":"Karolinska Institute Nobel C & Larsson, A. Functions of Glutathione\u202f: Biochemical, Physiological, Toxicological, and Clinical Aspects (Raven Press, 1983)."},{"issue":"18","key":"40497_CR8","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1021\/bi00232a031","volume":"30","author":"JP Richard","year":"1991","unstructured":"Richard, J. P. Kinetic parameters for the elimination reaction catalyzed by triosephosphate isomerase and an estimation of the reaction\u2019s physiological significance. Biochemistry 30(18), 4581\u20134585. https:\/\/doi.org\/10.1021\/bi00232a031 (1991).","journal-title":"Biochemistry"},{"key":"40497_CR9","first-page":"763","volume":"14","author":"C Sj","year":"1986","unstructured":"Sj, C. The glyoxalase enigma. The biological consequences of a ubiquitous enzyme. IRCS Med. Sci. 14, 763\u2013768 (1986).","journal-title":"IRCS Med. Sci."},{"key":"40497_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s0009-2797(97)00157-9","volume":"111-112","author":"PJ Thornalley","year":"1998","unstructured":"Thornalley, P. J. Glutathione-dependent detoxification of \u03b1-oxoaldehydes by the glyoxalase system: Involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chem. Biol. Interact. 111\u2013112, 137\u2013151. https:\/\/doi.org\/10.1016\/s0009-2797(97)00157-9 (1998).","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"40497_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1042\/bst0311343","volume":"31","author":"PJ Thornalley","year":"2003","unstructured":"Thornalley, P. J. Glyoxalase I--structure, function and a critical role in the enzymatic defence against glycation. Biochem. Soc. Trans. 31 (6), 1343\u20131348. https:\/\/doi.org\/10.1042\/bst0311343 (2003).","journal-title":"Biochem. Soc. Trans."},{"issue":"12","key":"40497_CR12","doi-asserted-by":"publisher","first-page":"13740","DOI":"10.3390\/molecules171213740","volume":"17","author":"Q Al-Balas","year":"2012","unstructured":"Al-Balas, Q. et al. Generation of the first structure-based pharmacophore model containing a selective \u201czinc binding group\u201d feature to identify potential glyoxalase-1 inhibitors. Molecules 17 (12), 13740\u201313758. https:\/\/doi.org\/10.3390\/molecules171213740 (2012).","journal-title":"Molecules"},{"issue":"7","key":"40497_CR13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1021\/ar9501232","volume":"29","author":"DW Christianson","year":"1996","unstructured":"Christianson, D. W. & Fierke, C. A. Carbonic anhydrase: Evolution of the Zinc binding site by nature and by design. Acc. Chem. Res. 29 (7), 331\u2013339. https:\/\/doi.org\/10.1021\/ar9501232 (1996).","journal-title":"Acc. Chem. Res."},{"issue":"3","key":"40497_CR14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.25258\/ijddt.15.3.27","volume":"15","author":"MI Al-Zuhairi","year":"2025","unstructured":"Al-Zuhairi, M. I., Shakya, A. K., Numan, N. A., Al-Tameemi, S. J. & Al-Qazzan, M. B. Evaluating the activity of Momordica charantia (Bitter Gourd) fruit and Curcuma longa (Turmeric) rhizome extract as anti-hyperlipidemic agents in experimental animals. Drug Deliv. 15 (3), 1101\u20131108. https:\/\/doi.org\/10.25258\/ijddt.15.3.27 (2025).","journal-title":"Drug Deliv."},{"issue":"41","key":"40497_CR15","doi-asserted-by":"publisher","first-page":"13480","DOI":"10.1021\/bi990696c","volume":"38","author":"AD Cameron","year":"1999","unstructured":"Cameron, A. D. et al. Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue. Biochemistry 38 (41), 13480\u201313490. https:\/\/doi.org\/10.1021\/bi990696c (1999).","journal-title":"Biochemistry"},{"issue":"12","key":"40497_CR16","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1093\/emboj\/16.12.3386","volume":"16","author":"AD Cameron","year":"1997","unstructured":"Cameron, A. D., Olin, B., Ridderstr\u00f6m, M., Mannervik, B. & Jones, T. A. Crystal structure of human glyoxalase I--evidence for gene duplication and 3D domain swapping. EMBO J. 16 (12), 3386\u20133395. https:\/\/doi.org\/10.1093\/emboj\/16.12.3386 (1997).","journal-title":"EMBO J."},{"issue":"1","key":"40497_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1107\/s0108767307035623","volume":"64","author":"HM Berman","year":"2008","unstructured":"Berman, H. M. The Protein Data Bank: A historical perspective. Acta Crystallogr. A 64 (1), 88\u201395. https:\/\/doi.org\/10.1107\/s0108767307035623 (2008).","journal-title":"Acta Crystallogr. A"},{"issue":"41","key":"40497_CR18","doi-asserted-by":"publisher","first-page":"13480","DOI":"10.1021\/bi990696c","volume":"38","author":"AD Cameron","year":"1999","unstructured":"Cameron, A. D. et al. Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue. Biochemistry 38 (41), 13480\u201313490. https:\/\/doi.org\/10.1021\/bi990696c (1999).","journal-title":"Biochemistry"},{"issue":"24","key":"40497_CR19","doi-asserted-by":"publisher","first-page":"7486","DOI":"10.1016\/j.bmcl.2012.10.045","volume":"22","author":"T Chiba","year":"2012","unstructured":"Chiba, T. et al. Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors. Bioorg. Med. Chem. Lett. 22(24), 7486\u20137489. https:\/\/doi.org\/10.1016\/j.bmcl.2012.10.045 (2012).","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"40497_CR20","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1093\/emboj\/16.12.3386","volume":"16","author":"AD Cameron","year":"1997","unstructured":"Cameron, A. D., Olin, B., Ridderstr\u00f6m, M., Mannervik, B. & Jones, T. A. Crystal structure of human glyoxalase I_evidence for gene duplication and 3D domain swapping. EMBO J. 16 (12), 3386\u201395-95. https:\/\/doi.org\/10.1093\/emboj\/16.12.3386 (1997).","journal-title":"EMBO J."},{"issue":"2","key":"40497_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/protein\/gzm083","volume":"21","author":"VZ Spassov","year":"2008","unstructured":"Spassov, V. Z., Flook, P. K. & Yan, L. LOOPER: A molecular mechanics-based algorithm for protein loop prediction. Protein Eng. Des. Select. PEDS 21 (2), 91\u2013100 (2008).","journal-title":"Protein Eng. Des. Select. PEDS"},{"issue":"11","key":"40497_CR22","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1110\/ps.036335.108","volume":"17","author":"VZ Spassov","year":"2008","unstructured":"Spassov, V. Z. & Yan, L. A fast and accurate computational approach to protein ionization. Protein Sci. 17 (11), 1955\u20131970. https:\/\/doi.org\/10.1110\/ps.036335.108 (2008).","journal-title":"Protein Sci."},{"key":"40497_CR23","unstructured":"Scientific TF. Properties & profile of the maybridge screening collection. (2025)."},{"issue":"20","key":"40497_CR24","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1021\/jm050362n","volume":"49","author":"GL Warren","year":"2006","unstructured":"Warren, G. L. et al. A critical assessment of docking programs and scoring functions. J. Med. Chem. 49 (20), 5912\u20135931. https:\/\/doi.org\/10.1021\/jm050362n (2006).","journal-title":"J. Med. Chem."},{"key":"40497_CR25","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673338657251018045851","author":"M Alzghoul","year":"2026","unstructured":"Alzghoul, M. et al. Unique bidentate chelators of functionalized heterocyclic fluoroquinolones with dual anti-inflammatory and selective cytotoxic effects via a C7\u2013C8 ethylene diamine bridge. Curr. Med. Chem. https:\/\/doi.org\/10.2174\/0109298673338657251018045851 (2026).","journal-title":"Curr. Med. Chem."},{"issue":"10","key":"40497_CR26","doi-asserted-by":"publisher","first-page":"e0333405","DOI":"10.1371\/journal.pone.0333405","volume":"20","author":"M Al-Qazzan","year":"2025","unstructured":"Al-Qazzan, M. et al. Cytotoxic, anti-inflammatory, antioxidant, and anti-glyoxalase-I evaluation of chelating substances: In silico and in vitro study. PLoS ONE 20 (10), e0333405. https:\/\/doi.org\/10.1371\/journal.pone.0333405 (2025).","journal-title":"PLoS ONE"},{"issue":"1","key":"40497_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.25122\/jml-2023-0257","volume":"17","author":"M Al-Akeedi","year":"2024","unstructured":"Al-Akeedi, M., Najdawi, M., Al-Balas, Q., Al-Qazzan, M. B. & Telfah, S. T. Novel anthraquinone amide derivatives as potential glyoxalase-I inhibitors. J. Med. Life 17 (1), 87\u201398. https:\/\/doi.org\/10.25122\/jml-2023-0257 (2024).","journal-title":"J. Med. Life"},{"issue":"7","key":"40497_CR28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.4314\/tjpr.v24i7.10","volume":"24","author":"Z Mokhtar","year":"2025","unstructured":"Mokhtar, Z., Ali, A. J., Awad, S. H., Bashar, M. & Al-Qazzan, M. A. Preparation of new Schiff base derivatives from chitosan grafted with polyvinylpyrrolidone and study of their antimicrobial activity. Trop. J. Pharm. Res. 24 (7), 935\u2013948. https:\/\/doi.org\/10.4314\/tjpr.v24i7.10 (2025).","journal-title":"Trop. J. Pharm. Res."},{"key":"40497_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/AABC.S441074","volume":"17","author":"MH Fetian","year":"2024","unstructured":"Fetian, M. H. & Al-Balas, Q. A. Unraveling potential glyoxalase-I inhibitors utilizing structure-based drug design techniques. Adv. Appl. Bioinform. Chem. 17, 21\u201332. https:\/\/doi.org\/10.2147\/AABC.S441074 (2024).","journal-title":"Adv. Appl. Bioinform. Chem."},{"issue":"1","key":"40497_CR30","doi-asserted-by":"publisher","first-page":"2301758","DOI":"10.1080\/14756366.2024.2301758","volume":"39","author":"RS Bibars","year":"2024","unstructured":"Bibars, R. S. & Al-Balas, Q. A. Computational fragment-based drug design of potential Glo-I inhibitors. J. Enzyme Inhib. Med. Chem. 39 (1), 2301758. https:\/\/doi.org\/10.1080\/14756366.2024.2301758 (2024).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"5","key":"40497_CR31","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.bbagen.2014.08.004","volume":"1850","author":"K Vanommeslaeghe","year":"2015","unstructured":"Vanommeslaeghe, K. & MacKerell, A. D. CHARMM additive and polarizable force fields for biophysics and computer-aided drug design. Biochim. Biophys. Acta (BBA) General Sub. 1850 (5), 861\u2013871. https:\/\/doi.org\/10.1016\/j.bbagen.2014.08.004 (2015).","journal-title":"Biochim. Biophys. Acta (BBA) General Sub."},{"issue":"6","key":"40497_CR32","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1021\/acs.jctc.5c00046","volume":"21","author":"A Croitoru","year":"2025","unstructured":"Croitoru, A. et al. Increasing the accuracy and robustness of the CHARMM general force field with an expanded training set. J. Chem. Theory Comput. 21 (6), 3044\u20133065. https:\/\/doi.org\/10.1021\/acs.jctc.5c00046 (2025).","journal-title":"J. Chem. Theory Comput."},{"issue":"20","key":"40497_CR33","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.2174\/138161212800672705","volume":"18","author":"C Julio","year":"2012","unstructured":"Julio, C. & Jans, H.A.-M. Molecular dynamics of protein kinase-inhibitor complexes: A valid structural information. Curr. Pharm. Des. 18 (20), 2946\u20132963. https:\/\/doi.org\/10.2174\/138161212800672705 (2012).","journal-title":"Curr. Pharm. Des."},{"key":"40497_CR34","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.2147\/dddt.S110997","volume":"10","author":"QA Al-Balas","year":"2016","unstructured":"Al-Balas, Q. A. et al. Novel glyoxalase-I inhibitors possessing a \u201czinc-binding feature\u201d as potential anticancer agents. Drug Des. Devel. Ther. 10, 2623\u20132629. https:\/\/doi.org\/10.2147\/dddt.S110997 (2016).","journal-title":"Drug Des. Devel. Ther."},{"key":"40497_CR35","doi-asserted-by":"publisher","DOI":"10.2174\/1570180814666170306120954","author":"QA Al-Balasa","year":"2017","unstructured":"Al-Balasa, Q. A. et al. Novel thiazole carboxylic acid derivatives possessing a \u201czinc binding feature\u201d as potential human glyoxalase-I inhibitors. Lett. Drug Design Discov. https:\/\/doi.org\/10.2174\/1570180814666170306120954 (2017).","journal-title":"Lett. Drug Design Discov."},{"key":"40497_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cells10081852","author":"G Aragon\u00e8s","year":"2021","unstructured":"Aragon\u00e8s, G. et al. The glyoxalase system in age-related diseases: Nutritional intervention as anti-ageing strategy. Cells https:\/\/doi.org\/10.3390\/cells10081852 (2021).","journal-title":"Cells"},{"issue":"4","key":"40497_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1389557518666181009141231","volume":"19","author":"QA Al-Balas","year":"2019","unstructured":"Al-Balas, Q. A., Hassan, M. A., Al-Shar\u2019i, N. A., Al Jabal, G. A. & Almaaytah, A. M. Recent advances in glyoxalase-I inhibition. Mini Rev. Med. Chem. 19 (4), 281\u2013291. https:\/\/doi.org\/10.2174\/1389557518666181009141231 (2019).","journal-title":"Mini Rev. Med. Chem."},{"key":"40497_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.compbiolchem.2019.03.011","volume":"80","author":"MA Al-Sha\u2019er","year":"2019","unstructured":"Al-Sha\u2019er, M. A., Al-Balas, Q. A., Hassan, M. A., Al Jabal, G. A. & Almaaytah, A. M. Combination of pharmacophore modeling and 3D-QSAR analysis of potential glyoxalase-I inhibitors as anticancer agents. Comput. Biol. Chem. 80, 102\u2013110. https:\/\/doi.org\/10.1016\/j.compbiolchem.2019.03.011 (2019).","journal-title":"Comput. Biol. Chem."},{"issue":"16","key":"40497_CR39","doi-asserted-by":"publisher","first-page":"115608","DOI":"10.1016\/j.bmc.2020.115608","volume":"28","author":"BA Al-Oudat","year":"2020","unstructured":"Al-Oudat, B. A. et al. Design, synthesis and biological evaluation of novel glyoxalase I inhibitors possessing diazenylbenzenesulfonamide moiety as potential anticancer agents. Bioorg. Med. Chem. 28 (16), 115608. https:\/\/doi.org\/10.1016\/j.bmc.2020.115608 (2020).","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"40497_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/1573406417666210714170403","volume":"18","author":"QA Al-Balas","year":"2022","unstructured":"Al-Balas, Q. A., Al-Sha\u2019er, M. A., Hassan, M. A. & Al Zou\u2019bi, E. Identification of the first \u201cTwo Digit Nano-molar\u201d inhibitors of the human Glyoxalase-I enzyme as potential anticancer agents. Med. Chem. 18 (4), 473\u2013483. https:\/\/doi.org\/10.2174\/1573406417666210714170403 (2022).","journal-title":"Med. Chem."},{"key":"40497_CR41","doi-asserted-by":"crossref","unstructured":"Hassan KH, Al-hussaniy Ha, Ibraim Oraibi A, Bashar Al-Qazzan M, Zainee HY, Al-Jashamy K, et al. Thermodynamic and Kinetic Assessment of Cobalt II Adsorption Using Green Synthesized NiO\/\u03b3-Al2O3 Nanoparticles. Salud, Ciencia y Tecnolog\u00eda - Serie de Conferencias. (2025).","DOI":"10.56294\/sctconf20251167"},{"key":"40497_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1, 19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001 (2015).","journal-title":"SoftwareX"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40497-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40497-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40497-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:02:23Z","timestamp":1774569743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40497-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40497"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40497-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9945"}}